| 发明名称 |
COMBINATION THERAPY INVOLVING A VASCULAR DISRUPTING AGENT AND AN AGENT WHICH TARGETS HYPOXIA |
| 摘要 |
The present invention provides a method for treating a proliferative disease in a patient. The method comprises administering to a patient in need thereof: a) a vascular disrupting agent and (b) at least one hypoxia targeting agent. Preferred combinations are BNC105 and Pazopanib and BNC 105 and Bortezomib. |
| 申请公布号 |
WO2013177633(A1) |
申请公布日期 |
2013.12.05 |
| 申请号 |
WO2013AU00581 |
申请日期 |
2013.06.03 |
| 申请人 |
BIONOMICS LIMITED |
发明人 |
INGLIS, DANIEL, J;LAVRANOS, TINA, C.;KREMMIDIOTIS , GABRIEL |
| 分类号 |
A61K31/343;A61K31/381;A61K31/404;A61K31/44;A61K31/506;A61K31/53;A61K31/661;A61K31/69;A61P35/00 |
主分类号 |
A61K31/343 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
